Foghorn Therapeutics Inc. (FHTX)
NASDAQ: FHTX · Real-Time Price · USD
4.220
+0.190 (4.71%)
Jun 26, 2026, 4:00 PM EDT - Market closed
Foghorn Therapeutics Employees
Foghorn Therapeutics had 106 employees as of December 31, 2025. The number of employees decreased by 6 or -5.36% compared to the previous year.
Employees
106
Change (1Y)
-6
Growth (1Y)
-5.36%
Revenue / Employee
$266,264
Profits / Employee
-$710,604
Market Cap
247.77M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Fate Therapeutics | 161 |
| Coherus Oncology | 145 |
| AC Immune | 122 |
| Orchestra BioMed Holdings | 86 |
| Fulcrum Therapeutics | 55 |
| Protara Therapeutics | 46 |
| ALX Oncology Holdings | 43 |
| Anavex Life Sciences | 34 |
FHTX News
- 18 days ago - Foghorn Therapeutics Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026 - Transcripts
- 22 days ago - Foghorn Therapeutics to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference 2026 - GlobeNewsWire
- 6 weeks ago - Foghorn Therapeutics to Participate in Three Upcoming Investor Conferences in May - GlobeNewsWire
- 7 weeks ago - Foghorn Therapeutics reports Q1 EPS (29c), consensus (31c) - TheFly
- 7 weeks ago - Foghorn Therapeutics Provides First Quarter 2026 Financial and Corporate Update - GlobeNewsWire
- 7 weeks ago - Foghorn Therapeutics Quarterly report: Q1 2026 - Filings
- 7 weeks ago - Foghorn Therapeutics Earnings release: Q1 2026 - Filings
- 7 weeks ago - Foghorn Therapeutics Slides: Investor presentation - Filings